annual CFF:
$332.11M+$162.28M(+95.56%)Summary
- As of today (July 1, 2025), OCUL annual cash flow from financing activities is $332.11 million, with the most recent change of +$162.28 million (+95.56%) on December 31, 2024.
- During the last 3 years, OCUL annual CFF has risen by +$329.26 million (+11548.90%).
- OCUL annual CFF is now at all-time high.
Performance
OCUL Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$4.18M-$330.00K(-7.31%)Summary
- As of today (July 1, 2025), OCUL quarterly cash flow from financing activities is $4.18 million, with the most recent change of -$330.00 thousand (-7.31%) on March 31, 2025.
- Over the past year, OCUL quarterly CFF has dropped by -$317.04 million (-98.70%).
- OCUL quarterly CFF is now -98.70% below its all-time high of $321.22 million, reached on March 31, 2024.
Performance
OCUL quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$15.07M-$317.04M(-95.46%)Summary
- As of today (July 1, 2025), OCUL TTM cash flow from financing activities is $15.07 million, with the most recent change of -$317.04 million (-95.46%) on March 31, 2025.
- Over the past year, OCUL TTM CFF has dropped by -$475.90 million (-96.93%).
- OCUL TTM CFF is now -96.93% below its all-time high of $490.97 million, reached on March 31, 2024.
Performance
OCUL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OCUL Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.6% | -98.7% | -96.9% |
| 3 y3 years | +10000.0% | +3142.6% | +263.8% |
| 5 y5 years | +340.8% | -67.4% | -83.5% |
OCUL Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -98.7% | +5262.8% | -96.9% | +974.1% |
| 5 y | 5-year | at high | >+9999.0% | -98.7% | +460.0% | -96.9% | +974.1% |
| alltime | all time | at high | >+9999.0% | -98.7% | +460.0% | -96.9% | +3412.1% |
OCUL Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.18M(-7.3%) | $15.07M(-95.5%) |
| Dec 2024 | $332.11M(+95.6%) | $4.51M(+8.0%) | $332.11M(-23.8%) |
| Sep 2024 | - | $4.18M(+90.3%) | $435.77M(-9.9%) |
| Jun 2024 | - | $2.20M(-99.3%) | $483.52M(-1.5%) |
| Mar 2024 | - | $321.22M(+197.0%) | $490.97M(+189.1%) |
| Dec 2023 | $169.83M(>+9900.0%) | $108.17M(+108.3%) | $169.83M(+173.4%) |
| Sep 2023 | - | $51.94M(+438.5%) | $62.12M(+488.5%) |
| Jun 2023 | - | $9.64M(>+9900.0%) | $10.55M(+652.3%) |
| Mar 2023 | - | $78.00K(-83.0%) | $1.40M(-3.5%) |
| Dec 2022 | $1.45M(-49.0%) | $458.00K(+22.5%) | $1.45M(-12.6%) |
| Sep 2022 | - | $374.00K(-24.1%) | $1.66M(-15.5%) |
| Jun 2022 | - | $493.00K(+282.2%) | $1.97M(-52.5%) |
| Mar 2022 | - | $129.00K(-80.7%) | $4.14M(+45.3%) |
| Dec 2021 | $2.85M(-98.7%) | $667.00K(-1.8%) | $2.85M(-98.3%) |
| Sep 2021 | - | $679.00K(-74.5%) | $166.10M(+0.3%) |
| Jun 2021 | - | $2.67M(-329.5%) | $165.64M(-22.6%) |
| Mar 2021 | - | -$1.16M(-100.7%) | $214.03M(-6.1%) |
| Dec 2020 | $228.01M(+202.6%) | $163.91M(>+9900.0%) | $228.01M(+211.5%) |
| Sep 2020 | - | $220.00K(-99.6%) | $73.19M(-20.1%) |
| Jun 2020 | - | $51.06M(+298.4%) | $91.58M(+99.7%) |
| Mar 2020 | - | $12.82M(+41.0%) | $45.86M(-39.1%) |
| Dec 2019 | $75.34M(+9.8%) | $9.09M(-51.2%) | $75.34M(-8.8%) |
| Sep 2019 | - | $18.61M(+248.7%) | $82.58M(+9.6%) |
| Jun 2019 | - | $5.34M(-87.4%) | $75.34M(-1.8%) |
| Mar 2019 | - | $42.30M(+159.1%) | $76.71M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $68.64M(+114.4%) | $16.33M(+43.6%) | $68.64M(+28.3%) |
| Sep 2018 | - | $11.37M(+69.4%) | $53.52M(+22.5%) |
| Jun 2018 | - | $6.71M(-80.4%) | $43.67M(+15.7%) |
| Mar 2018 | - | $34.23M(+2738.1%) | $37.76M(+18.0%) |
| Dec 2017 | $32.01M(+5371.5%) | $1.21M(-21.1%) | $32.01M(+1.6%) |
| Sep 2017 | - | $1.53M(+92.1%) | $31.50M(+4.8%) |
| Jun 2017 | - | $796.00K(-97.2%) | $30.04M(+2.7%) |
| Mar 2017 | - | $28.48M(+4009.2%) | $29.25M(+4900.2%) |
| Dec 2016 | $585.00K(-99.1%) | $693.00K(+788.5%) | $585.00K(+192.5%) |
| Sep 2016 | - | $78.00K(+2500.0%) | $200.00K(-353.2%) |
| Jun 2016 | - | $3000.00(-101.6%) | -$79.00K(-100.1%) |
| Mar 2016 | - | -$189.00K(-161.4%) | $65.65M(-0.1%) |
| Dec 2015 | $65.70M(-16.8%) | $308.00K(-253.2%) | $65.70M(+0.6%) |
| Sep 2015 | - | -$201.00K(-100.3%) | $65.29M(-50.9%) |
| Jun 2015 | - | $65.73M(<-9900.0%) | $133.04M(+67.8%) |
| Mar 2015 | - | -$137.00K(+29.2%) | $79.27M(+0.4%) |
| Dec 2014 | $78.97M(+1081.7%) | -$106.00K(-100.2%) | $78.97M(+0.4%) |
| Sep 2014 | - | $67.56M(+465.1%) | $78.63M(+640.5%) |
| Jun 2014 | - | $11.95M(-2860.7%) | $10.62M(+58.4%) |
| Mar 2014 | - | -$433.00K(-3.6%) | $6.71M(+0.3%) |
| Dec 2013 | $6.68M(-75.5%) | -$449.00K(-1.1%) | $6.68M(-6.3%) |
| Sep 2013 | - | -$454.00K(-105.6%) | $7.13M(-6.0%) |
| Jun 2013 | - | $8.04M(-1867.3%) | $7.59M(-1767.3%) |
| Mar 2013 | - | -$455.00K | -$455.00K |
| Dec 2012 | $27.30M | - | - |
FAQ
- What is Ocular Therapeutix annual cash flow from financing activities?
- What is the all time high annual CFF for Ocular Therapeutix?
- What is Ocular Therapeutix annual CFF year-on-year change?
- What is Ocular Therapeutix quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly CFF year-on-year change?
- What is Ocular Therapeutix TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ocular Therapeutix?
- What is Ocular Therapeutix TTM CFF year-on-year change?
What is Ocular Therapeutix annual cash flow from financing activities?
The current annual CFF of OCUL is $332.11M
What is the all time high annual CFF for Ocular Therapeutix?
Ocular Therapeutix all-time high annual cash flow from financing activities is $332.11M
What is Ocular Therapeutix annual CFF year-on-year change?
Over the past year, OCUL annual cash flow from financing activities has changed by +$162.28M (+95.56%)
What is Ocular Therapeutix quarterly cash flow from financing activities?
The current quarterly CFF of OCUL is $4.18M
What is the all time high quarterly CFF for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly cash flow from financing activities is $321.22M
What is Ocular Therapeutix quarterly CFF year-on-year change?
Over the past year, OCUL quarterly cash flow from financing activities has changed by -$317.04M (-98.70%)
What is Ocular Therapeutix TTM cash flow from financing activities?
The current TTM CFF of OCUL is $15.07M
What is the all time high TTM CFF for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM cash flow from financing activities is $490.97M
What is Ocular Therapeutix TTM CFF year-on-year change?
Over the past year, OCUL TTM cash flow from financing activities has changed by -$475.90M (-96.93%)